Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Recruiting × Ifosfamide × Clear all

Phase

Phase 2 16 Phase 3 7 Phase 1/2 3 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Unknown 2 Active not recruiting 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

Cisplatin 22 pembrolizumab 16 Gemcitabine 14 Drug Therapy 14 Carboplatin 14 Paclitaxel 13 Dexamethasone 12 Magnetic Resonance Spectroscopy 10 Bevacizumab 10 venetoclax 8 atezolizumab 8 Docetaxel 8 Specimen Handling 7 Pemetrexed 7 Oxaliplatin 7 Nivolumab 7 Cyclophosphamide 7 Radiotherapy 6 Methotrexate 6 Capecitabine 6 130-nm albumin-bound paclitaxel 6 durvalumab 5 Standard of Care 5 Cytarabine 5 Androgen Antagonists 5 tislelizumab 4 spartalizumab 4 pertuzumab 4 blinatumomab 4 Vincristine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡